Latest filing published 16 Oct 2026 for Biomark Diagnostics Inc., €2,512. Read the official filing
All filings by Rashid Ahmed Maula Bux on record concern Biomark Diagnostics Inc. Between 19 May 2026 and 16 October 2026, the trades on record add up to 31 filings.
Purchases make up the whole of the open-market record (31 purchases, €36k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The median purchase comes to €457. As a share of market capitalisation, the median purchase stands at 0.0013%, based on 28 purchases. None of the 31 purchases we analysed coincided with buying by another insider of the same company within 30 days.
The newest entry dates from 16 October 2026: an open-market purchase of €2,512, in Biomark Diagnostics Inc. The median gap between a trade and its publication by SEDI is 2 days. The shorter that gap, the sooner other investors can see what insiders have done. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 31 declarations